LOEWEN ANDREA (SVP, Global Regulatory Affairs) sold 10.1% of their position (3.17K shares) of REATA PHARMACEUTICALS INC on the open market
Open‑market sale worth $546.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/18/2023ACC: 0001209191-23-049792
Officer· SVP, Global Regulatory Affairs
Since Feb 2022
-3.17K
Net shares
Net seller
$546.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.17K disposed
Non-Derivative Transactions1
Class A common stock
Direct
Shares
−3.17K
Price / share
$172.03
Trade value
$546.18K
% of position
10.1%
9/14/2023
31.59K→28.42K
Total
Net shares
−3.17K
Net value
-$546.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A common stock Direct | 9/14/2023 | S · Sale | −3.17K | $172.03 | $546.18K | 10.1% | 31.59K | 28.42K |
| Total | −3.17K | -$546.18K | ||||||
Derivative Transactions0
No derivative transactions reported